Osteoarthritis - management options in general practice.
BACKGROUND
Osteoarthritis, characterised by joint pain and stiffness, is a common and significant chronic disease, reducing mobility and causing considerable impact on quality of life. Multiple evidence based management options are available.


OBJECTIVE
The aim of this article is to summarise the main management options suggested in The Royal Australian College of General Practitioners Guideline for the nonsurgical management of hip and knee osteoarthritis and to also highlight those that are not recommended.


CONCLUSIONS
Following diagnosis based primarily on history and examination, management focuses on optimising quality of life by providing self management advice combined with appropriate pharmacological and nonpharmacological strategies, aiming to reduce acute exacerbations, prevent complications and delay progression.
McKenzie
Suzanne
S
General Practice and Rural Medicine, School of Medicine & Dentistry, James Cook University, Townsville, Queensland. mckenzie1@jcu.edu.au
Torkington
Amanda
A
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D002807:Chondroitin / Q000627:therapeutic use; D002908:Chronic Disease; D018450:Disease Progression; D005944:Glucosamine / Q000627:therapeutic use; D006801:Humans; D007270:Injections, Intra-Articular; D010003:Osteoarthritis / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care
D000305:Adrenal Cortex Hormones; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002807:Chondroitin; D005944:Glucosamine